Free Trial

Atos (OTCMKTS:AEXAY) Shares Gap Down - Here's What Happened

Atos logo with Business Services background

Atos SE (OTCMKTS:AEXAY - Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $4.84, but opened at $4.35. Atos shares last traded at $4.35, with a volume of 225 shares.

Atos Stock Up 60.9%

The stock's fifty day moving average price is $4.90 and its two-hundred day moving average price is $2.19.

Atos Company Profile

(Get Free Report)

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms.

Recommended Stories

Should You Invest $1,000 in Atos Right Now?

Before you consider Atos, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atos wasn't on the list.

While Atos currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines